1 / 7

Oligonucleotide Synthesis Market Forecast to 2021

The global oligonucleotide synthesis market is expected to reach USD 2.20 Billion by 2021 from USD 1.33 Billion in 2016, at a CAGR of 10.6% during the forecast period. <br>

Download Presentation

Oligonucleotide Synthesis Market Forecast to 2021

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Click to Edit Title Click to Edit Title

  2. The report "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom, Predesigned, Reagent Equipment), Application (Research, PCR, Gene, DNA, NGS, Diagnostic, RNAI), End user (Academic, Pharmaceutical, Biotechnology) - Forecasts to 2021" ,The global oligonucleotide synthesis market is expected to reach USD 2.20 Billion by 2021 from USD 1.33 Billion in 2016, at a CAGR of 10.6% during the forecast period. Browse 229 market data tables and 53 figures spread through 248 pages and in- depth TOC on “Oligonucleotide Synthesis Market “ http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis- market-200829350.html​Early buyers will receive 10% customization on this reports The growth of this market is mainly driven by factors such as increasing R&D expenditure in pharmaceutical and biotechnology companies, increased use in clinical applications and molecular diagnostics, increasing government investments.

  3. The report segments the oligonucleotide synthesis market based on product and services, applications, end user, and region. On the basis of products and services, the oligonucleotide synthesis market is segmented into synthesized oligonucleotides, reagents, and equipment. Synthesized oligonucleotides are expected to account for the largest share of oligonucleotide synthesis market, in 2016. The growth of the synthesized oligonucleotides segment is attributed to the increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics. The rising demand for custom oligos also contributes to the growth of the synthesized oligonucleotides market. On the basis of application the oligonucleotide synthesis market is further segmented into research, diagnostic and therapeutics. Research segment is expected to account for the largest share of oligonucleotide synthesis market in 2016. Diagnostic segment is expected to grow at the highest CAGR during the forecast period.

  4. The growth of this segment is mainly attributed to the emerging application of molecular diagnostics (MDx) and genetic testing. The increasing use of technologies such as DNA microarrays in the analysis of biological samples and developing molecular oncology diagnostics tests also contribute in the growth of molecular diagnostics market. The Sample Report For This Report@ http://www.marketsandmarkets.com/requestsample.asp?id=200829350 On the basis of end-user the oligonucleotide synthesis market is categorized into academic research institutes, diagnostic laboratories, pharmaceutical and biotechnology companies, and other end users (private research institutes and hospitals). In 2016, the academic research institutes segment is expected to be the major end-user segment in the oligonucleotide synthesis market. Academic researchers primarily use oligonucleotides for various applications in genetic engineering, polymerase chain reaction (PCR) activities, and high-throughput sequencing.

  5. The oligonucleotide synthesis market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. However, the Asia-Pacific market is expected to grow at the highest CAGR, mainly due to the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the APAC region. Furthermore, the increasing focus of prominent players on APAC is another factor driving the growth of this market. Get The PDF Brochure For This Report@ http://www.marketsandmarkets.com/pdfdownload.asp?id=200829350 The oligonucleotide synthesis market is a highly fragmented market, with several big and emerging players. Key market players include Bioautomation Corporation (U.S.), L.G.C Biosearch Technologies, Inc. (U.S.), Eurofins Genomics (Germany), Eurogentec S.A (Belgium), GE Healthcare (U.S.), Integrated DNA Technologies (IDT) (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies (U.S.), Nitto Denko Avecia Inc. (U.S.).

  6. MEDIUM TEXT

  7. Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: sales@marketsandmarkets.com ​MarketsandMarkets Blog​http://www.marketsandmarkets.com​http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets

More Related